Search

Search Results
Results 211 - 220 of 716 for Vaccines
  • Supplier Profile
    Cytiva, we are a global provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. Our rich heritage dates back...
  • Supplier Profile
    The Scripps Research Institute, one of the country's largest, private, non-profit research organizations, has always stood at the forefront of basic biomedical science, a vital segment of medical...
  • News - 15 Oct 2012
    Genetic Immunity, a leader in immunotherapy technology product development, and DKFZ (German Cancer Research Center, Heidelberg, Germany) signed a collaborative agreement to develop a DNA-based...
  • Supplier Profile
    At CryoSol, we believe innovation in vitrification sample preparation technology is of vital importance to advance cryo-electron microscopy results. The world needs reliable and reproducible solutions...
  • Supplier Profile
    Novavax, Inc. is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on drug delivery and biological technologies. The...
  • Supplier Profile
    Monogram is a leader in developing and commercializing innovative products to help guide and improve the treatment of infectious diseases, cancer and other serious diseases. Our molecular diagnostics...
  • News - 29 Mar 2019
    Cornell scientists have developed a new family of biomaterial for an infectious disease. Nanovaccine successfully boosted immunity in mice with metabolic disorders associated with gut bacteria—a...
  • Supplier Profile
    Colloids and interfaces consist of very small or thin structures with linear dimensions between nanometers and micrometers. On the one hand, the possible struxctures represent a „world of hidden...
  • News - 4 Dec 2013
    A UConn research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, a discovery that could lead to the development of stable vaccines and affordable artificial...
  • News - 7 Dec 2009
    NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.